Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation
source: pixabay.com

Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation

According to a story from BioSpace, the biotechnology company Ascentage Pharma has just announced that it has been given Orphan Drug designation from the US Food and Drug Administration (FDA).…

Continue Reading Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation
Problems with Eyesight Prevalent in Parkinson’s Disease as Patients Age, Study Finds
source: pixabay.com

Problems with Eyesight Prevalent in Parkinson’s Disease as Patients Age, Study Finds

According to a story from Parkinson's News Today, older patients with Parkinson's disease appear to have a higher than average rates of vision problems. These issues are also associated with…

Continue Reading Problems with Eyesight Prevalent in Parkinson’s Disease as Patients Age, Study Finds
Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available
source: pixabay.com

Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

According to a story from Physician's Weekly, while measuring the concentration of albumin (albuminuria) is widely considered the standard method for staging and screening for chronic kidney disease, a different…

Continue Reading Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available